Sadao Hirota
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 7
- Lipid Membrane Structure and Behavior 7
- DNA and Nucleic Acid Chemistry 4
- Glycosylation and Glycoproteins Research 3
- Biomaterials 14
- Nanoparticle-Based Drug Delivery 13
- Co-authors
- Yasuyuki Sadzuka (26 shared papers)Tomomi Sugiyama (3 shared papers)Takashi Sonobe (3 shared papers)Atsuo Miyagishima (13 shared papers)Yasuo Nozawa (13 shared papers)Kazuhiko Shimada (2 shared papers)Hitoshi Yamauchi (3 shared papers)Hiroshi Kikuchi (3 shared papers)
- Journals
- Chemical and Pharmaceutical Bulletin (11 papers)Cancer Letters (4 papers)Journal of Liposome Research (3 papers)Pharmaceutica Acta Helvetiae (3 papers)International Journal of Pharmaceutics (3 papers)
- Partner nations
- JapanUnited StatesNetherlands
In The Last Decade
Sadao Hirota
49 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 97
- Pharmaceutical Science 167
- Biomaterials 318
- Biochemistry 59
- Applied Microbiology and Biotechnology 16
- Pathology and Forensic Medicine 141
Countries citing papers authored by Sadao Hirota
This map shows the geographic impact of Sadao Hirota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sadao Hirota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sadao Hirota more than expected).
Fields of papers citing papers by Sadao Hirota
This network shows the impact of papers produced by Sadao Hirota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sadao Hirota. The network helps show where Sadao Hirota may publish in the future.
Co-authors
The 25 scholars most cited alongside Sadao Hirota, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 119 | |
| 2 | 1996 | 90 | |
| 3 | 1997 | 81 | |
| 4 | 1997 | 70 | |
| 5 | Modulation of cancer chemotherapy by green tea. | 1998 | 68 |
| 6 | 1998 | 64 | |
| 7 | 1996 | 61 | |
| 8 | 2000 | 54 | |
| 9 | 1999 | 49 | |
| 10 | 2003 | 47 | |
| 11 | 1991 | 43 | |
| 12 | 1994 | 42 | |
| 13 | 1991 | 36 | |
| 14 | 1999 | 34 | |
| 15 | 1997 | 31 | |
| 16 | 1994 | 29 | |
| 17 | 1997 | 27 | |
| 18 | 1995 | 22 | |
| 19 | 1995 | 18 | |
| 20 | 1993 | 16 |
About Sadao Hirota
Sadao Hirota is a scholar working on Molecular Biology, Biomaterials, Cardiology and Cardiovascular Medicine, Oncology and Organic Chemistry, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (13 papers), Chemotherapy-induced cardiotoxicity and mitigation (8 papers), RNA Interference and Gene Delivery (7 papers), Lipid Membrane Structure and Behavior (7 papers), Drug Solubulity and Delivery Systems (5 papers), Analytical Chemistry and Chromatography (4 papers), DNA and Nucleic Acid Chemistry (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Pharmaceutical Science (167 citations), Biomaterials (318 citations), Biochemistry (59 citations), Applied Microbiology and Biotechnology (16 citations) and Pathology and Forensic Medicine (141 citations). Sadao Hirota has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Yasuyuki Sadzuka, Tomomi Sugiyama, Takashi Sonobe, Atsuo Miyagishima, Yasuo Nozawa, Kazuhiko Shimada, Hitoshi Yamauchi, Hiroshi Kikuchi, Reiner Zeisig and Kayoko Shimoi. Their work appears in journals such as Chemical and Pharmaceutical Bulletin, Cancer Letters, Journal of Liposome Research, Pharmaceutica Acta Helvetiae and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.